Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis
Tài liệu tham khảo
Acha-Orbea, 1988, Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention, Cell, 54, 263, 10.1016/0092-8674(88)90558-2
Allegretta, 1990, T cells responsive to myelin basic protein in patients with multiple sclerosis, Science, 247, 718, 10.1126/science.1689076
Beall, 1987, Analysis of the germline V beta and V alpha genes in patients with multiple sclerosis, J. Cell Biochem., 11D, 223
Bourdette, 1988, Basic protein-specific T-cell lines that induce experimental autoimmune encephalomyelitis in SJL/J mice: Comparison with Lewis rats, Cell Immunol., 112, 351, 10.1016/0008-8749(88)90304-8
Bourdette, 1991, Myelin basic protein specific T cell lines and clones derived from the CNS of rats with EAE only recognize encephalitogenic epitopes, J. Neurosci. Res., 30, 305, 10.1002/jnr.490300205
Burger, 1977, De novo appearance of KLH transfer factor following immunization, Cell Immunol., 29, 410, 10.1016/0008-8749(77)90336-7
Cohen, 1987, Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis, Cell Immunol., 108, 203, 10.1016/0008-8749(87)90204-8
Elian, 1987, Multiple sclerosis among the United Kingdom-borm children of immigrants from the West Indies, J. Neurol. Neurosurg. Psychiatry, 50, 327, 10.1136/jnnp.50.3.327
Eylar, 1971, Basic A1 protein of the myelin membrane: The complete amino acid sequence, J. Biol. Chem., 246, 5770, 10.1016/S0021-9258(18)61872-1
Fallis, 1987, Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis analyses of basic protein-reactive cells in lymphoid organs and nervous system of donor and recopient animals, J. Neuroimmunol., 14, 205, 10.1016/0165-5728(87)90055-5
Ford, 1983, Precursor frequency of antigen-specific T cells: effects of sensitization in vivo and in vitro, Cell Immunol., 9, 334, 10.1016/0008-8749(83)90075-8
Francis, 1986, Multiple sclerosis and HLA DQw1, Lancet, i, 211, 10.1016/S0140-6736(86)90684-7
Geha, 1981, Dynamics of human circulating antigen reactive cells following secondary immunization with tetanus toxoid, Clin. Immunol. Immunopathol., 19, 196, 10.1016/0090-1229(81)90063-5
Hafler, 1987, Myelin basic protein and proteolipid protein reactivity of brain- and cerebrospinal fluid-derived T cell clones in multiple sclerosis and postinfectious encephalomyelitis, J. Immunol., 139, 68, 10.4049/jimmunol.139.1.68
Hashim, 1985, Myelin basic protein responsive blood T lymphocytes in patients with multiple sclerosis, J. Neurosci. Res., 13, 349, 10.1002/jnr.490130302
Hashim, 1990, Antibodies specific for a Vβ8 receptor peptide suppress experimental autoimmune ephalomyelitis, J. Immunol., 144, 4621, 10.4049/jimmunol.144.12.4621
Hauser, 1983, Intensive immunosuppression in progressive multiple slerosis: A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N., Engl. J. Med., 308, 173, 10.1056/NEJM198301273080401
Hauser, 1989, Extended major histocompatibility complex haplotypes in patients with multiple sclerosis, J. Neurol., 39, 275, 10.1212/WNL.39.2.275
Ho, 1982, HLA-linked and unlinked determinants of multiple sclerosis, Immunogenetics, 15, 509, 10.1007/BF00345910
Howell, 1989, Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides, Science, 246, 668, 10.1126/science.2814489
Hughes, 1968, Lymphocyte transformation induced by encephalitogenic factor in multiple sclerosis and other neurological diseases, Lancet, ii, 1205, 10.1016/S0140-6736(68)91690-5
Knight, 1977, Cellular immunity in multiple sclerosis, Br. Med. Bull., 33, 45, 10.1093/oxfordjournals.bmb.a071395
Kotzin, 1991, Preferential T cell receptor Vβ gene usage in myelin basic protein reactive T cell clones from patients with multiple sclerosis, 88, 9161
Kurtzke, 1965, Further notes on disability evaluation in multiple sclerosis with scale modification, Neurology, 15, 654, 10.1212/WNL.15.7.654
Lefkovits, 1984, Limiting dilution analysis of the cells of immune system 1 & 2. The clonal basis of the immune response, Immunol. Today, 5, 265, 10.1016/0167-5699(84)90137-3
Lefkovits, 1984, Limiting dilution analysis of the cells of immune system 1 & 2. The clonal basis of the immune response, Immunol. Today, 5, 295, 10.1016/0167-5699(84)90137-3
Lisak, 1974, Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis, Neurology, 24, 560, 10.1212/WNL.24.6.560
McFarlin, 1982, Multiple sclerosis, N. Engl. J. Med., 307, 1183, 10.1056/NEJM198211043071905
1990, Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double-blinded, placebo-controlled clinical trial, Ann. Neurol., 27, 591, 10.1002/ana.410270603
Offner, 1991, T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis, Science, 251, 430, 10.1126/science.1989076
Oksenberg, 1989, T-cell receptor V alpha and C alpha alleles associated with multiple sclerosis and myasthenia gravis, 86, 988
Olsson, 1990, Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ, J. Clin. Invest., 86, 981, 10.1172/JCI114800
Ota, 1990, T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis, Nature, 346, 183, 10.1038/346183a0
Perry, 1991, T cell sensitization to proteolipid protein in myelin basic protein-inducedd relapsing experimental allergic encephalomyelitis, J. Neuroimmunol., 33, 7, 10.1016/0165-5728(91)90029-7
Poser, 1983, New diagnostic criteria for multiple sclerosis: Guidelines for research protocols, Ann. Neurol., 13, 227, 10.1002/ana.410130302
Rose, 1970, Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH versus placebo, Neurology, 20, 1, 10.1212/WNL.20.5_Part_2.1
Sohnle, 1981, Lymphocyte transformation and the number of antigen-responsive cells in humans, J. Immunol., 127, 612, 10.4049/jimmunol.127.2.612
Spielman, 1982, The genetics of susceptibility to multiple sclerosis, Epidemiol. Rev., 4, 45, 10.1093/oxfordjournals.epirev.a036251
Sun, 1991, Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls, Eur. J. Immunol., 21, 1461, 10.1002/eji.1830210620
Traugott, 1985, Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions, Springer Semin. Immunopathol., 8, 71, 10.1007/BF00197248
Tuohy, 1988, A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis, J. Immunol., 141, 1126, 10.4049/jimmunol.141.4.1126
Urban, 1988, Restricted use of T cell receptor in genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy, Cell, 54, 577, 10.1016/0092-8674(88)90079-7
Vandenbark, 1989, Human T lymphocyte response to myelin basic protein: Selection of T lymphocyte lines from MBP-responsive donors, J. Neurosci. Res., 23, 21, 10.1002/jnr.490230104
Vandenbark, 1989, Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis, Nature, 341, 541, 10.1038/341541a0
Weiner, 1988, Immunotherapy of multiple sclerosis, Ann. Neurol., 23, 211, 10.1002/ana.410230302
Whitham, 1991, Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis, J. Immunol., 146, 101, 10.4049/jimmunol.146.1.101
Whitham, 1991, Location of a new encephalitogenic epitope (residues 43–64) in proteolipid protein which induces relapsing EAE in PL/J and (SJL × PL) F1 mice, J. Immunol., 147, 3803, 10.4049/jimmunol.147.11.3803
Wucherpfennig, 1990, Shared human T cell receptor Vβ usage to immunodominant region of myelin basic protein, Science, 248, 1016, 10.1126/science.1693015
Zamvil, 1985, T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination, Nature, 317, 355, 10.1038/317355a0
